PEP
36
3
HES
53
4
SYF
83
7
PNW
57
4
T
36
4
CVX
17
3
AON
30
2
KIM
60
3
ETR
65
4
PFE
33
-2
ADSK
63
2
PLD
40
2
ADM
27
2
OKE
67
5
NWSA
75
8
JNJ
39
4
SO
51
3
TEL
60
2
DIS
72
4
MDLZ
36
6
PEP
36
3
HES
53
4
SYF
83
7
PNW
57
4
T
36
4
CVX
17
3
AON
30
2
KIM
60
3
ETR
65
4
PFE
33
-2
ADSK
63
2
PLD
40
2
ADM
27
2
OKE
67
5
NWSA
75
8
JNJ
39
4
SO
51
3
TEL
60
2
DIS
72
4
MDLZ
36
6
Financhill
Back

Avenue Therapeutics 10K Form

Sell
20

ATXI
Avenue Therapeutics

Last Price:
$1.74
Seasonality Move:
9.82%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ATXI News And Ratings

See the #1 stock for the next 7 days that we like better than ATXI

ATXI Financial Statistics

Sales & Book Value

Annual Sales: --
Cash Flow: $-2.9M
Price / Cash Flow: 0
Annual Sales: $1.63
Price / Book: 1.35

Profitability

EPS (TTM): -21.87480
Net Income (TTM): $-14M
Gross Margin: --
Return on Equity: 0%
Return on Assets: 0%

Avenue Therapeutics Earnings Forecast

Key Avenue Therapeutics Financial Ratios

  • The Interest Expense is -3.20% of Operating Income.
  • Per Share Earnings over the last 8 years have been positive in 5 years.

Avenue Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: ATXI
CUSIP: 05360L
Website: avenuetx.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

ATXI Technical Analysis vs Fundamental Analysis

Sell
20
Avenue Therapeutics (ATXI) is a Sell

Is Avenue Therapeutics a Buy or a Sell?